Cargando…

Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients

BACKGROUND: Risk stratification, detection of minimal residual disease (MRD), and implementation of novel therapeutic agents have improved outcome in acute lymphoblastic leukemia (ALL), but survival of adult patients with T-cell acute lymphoblastic leukemia (T-ALL) remains unsatisfactory. Thus, nove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartram, Isabelle, Gökbuget, Nicola, Schlee, Cornelia, Heesch, Sandra, Fransecky, Lars, Schwartz, Stefan, Stuhlmann, Reingard, Schäfer-Eckhart, Kerstin, Starck, Michael, Reichle, Albrecht, Hoelzer, Dieter, Baldus, Claudia D, Neumann, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223626/ https://www.ncbi.nlm.nih.gov/pubmed/25023966 http://dx.doi.org/10.1186/s13045-014-0051-y

Ejemplares similares

FAT1 expression and mutations in adult acute lymphoblastic leukemia
por: Neumann, M, et al.
Publicado: (2014)

Mutational spectrum of adult T-ALL
por: Neumann, Martin, et al.
Publicado: (2014)

FLT3 Mutations in Early T-Cell Precursor ALL Characterize a Stem Cell Like Leukemia and Imply the Clinical Use of Tyrosine Kinase Inhibitors
por: Neumann, Martin, et al.
Publicado: (2013)

Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations
por: Neumann, M, et al.
Publicado: (2012)

Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment
por: Burmeister, Thomas, et al.
Publicado: (2023)

Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL
por: Fransecky, L., et al.
Publicado: (2016)

Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL
por: Bartram, Isabelle, et al.
Publicado: (2015)

Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia
por: Kobitzsch, Benjamin, et al.
Publicado: (2017)

FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling
por: Liebig, Sven, et al.
Publicado: (2023)

Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures
por: Schroeder, Michael P., et al.
Publicado: (2019)

Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia
por: James, Alva Rani, et al.
Publicado: (2019)

General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia
por: Gökbuget, Nicola, et al.
Publicado: (2023)

Dominant T-cell Receptor Delta Rearrangements in B-cell Precursor Acute Lymphoblastic Leukemia: Leukemic Markers or Physiological γδ T Repertoire?
por: Kelm, Miriam, et al.
Publicado: (2023)

Blinatumomab vs historic standard‐of‐care treatment for minimal residual disease in adults with B‐cell precursor acute lymphoblastic leukaemia
por: Gökbuget, Nicola, et al.
Publicado: (2020)

Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
por: Fransecky, Lars, et al.
Publicado: (2015)

Osteonecrosis in Adults With Acute Lymphoblastic Leukemia: An Unmet Clinical Need
por: Kuhlen, Michaela, et al.
Publicado: (2021)

bcl‐2 Regulation in Normal Resting Lymphocytes and Lymphoblasts
por: Kendo, Eisaku, et al.
Publicado: (1994)

An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapse
por: Bartsch, Lorenz, et al.
Publicado: (2022)

Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation
por: Lázaro-Navarro, Juan, et al.
Publicado: (2021)

Prognostic value of low-level MRD in adult acute lymphoblastic leukemia detected by low- and high-throughput methods
por: Kotrová, Michaela, et al.
Publicado: (2022)

BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy
por: Slone, William L., et al.
Publicado: (2016)

Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy
por: Lüke, Florian, et al.
Publicado: (2021)

Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia
por: Hurtz, Christian, et al.
Publicado: (2019)

Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
por: Gökbuget, N, et al.
Publicado: (2016)

Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia
por: Kaiser, M, et al.
Publicado: (2011)

RBP2 Promotes Adult Acute Lymphoblastic Leukemia by Upregulating BCL2
por: Wang, Xiaoming, et al.
Publicado: (2016)

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia
por: Chitadze, Guranda, et al.
Publicado: (2023)

No genetic evidence for involvement of Deltaretroviruses in adult patients with precursor and mature T-cell neoplasms
por: Burmeister, Thomas, et al.
Publicado: (2007)

S114: OUTCOME OF OLDER PATIENTS (>55 YRS) WITH NEWLY DIAGNOSED PH/BCR:ABL POSITIVE ALL PROSPECTIVELY TREATED ACCORDING TO PEDIATRIC-BASED, AGE-ADAPTED GMALL PROTOCOLS
por: Lang, Fabian, et al.
Publicado: (2023)

Clinician Concepts of Cure in Adult Relapsed and Refractory Philadelphia-Negative B Cell Precursor Acute Lymphoblastic Leukemia: A Delphi Study
por: Bassan, Renato, et al.
Publicado: (2019)

Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia
por: Summers, Ryan J., et al.
Publicado: (2022)

Systems Biology: A Therapeutic Target for Tumor Therapy
por: Reichle, Albrecht, et al.
Publicado: (2008)

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements
por: McPhail, Ellen D., et al.
Publicado: (2018)

ERG Transcriptional Networks in Primary Acute Leukemia Cells Implicate a Role for ERG in Deregulated Kinase Signaling
por: Bock, Juliane, et al.
Publicado: (2013)

BCL6 inhibition ameliorates resistance to ruxolitinib in CRLF2-rearranged acute lymphoblastic leukemia
por: Tsuzuki, Shinobu, et al.
Publicado: (2022)

Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia
por: Zugmaier, G, et al.
Publicado: (2014)

Principles of Modular Tumor Therapy
por: Reichle, Albrecht, et al.
Publicado: (2009)

bcl-2-specific siRNAs restore Gemcitabine sensitivity in human pancreatic cancer cells
por: Okamoto, Kinya, et al.
Publicado: (2007)

High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis
por: Brenne, Anne-Tove, et al.
Publicado: (2009)

Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia
por: Ge, Zheng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qh03sve0cpph784oidg8mit5ii